These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 15567165)
1. Divergent effects of estrogen and nicotine on Rho-kinase expression in human coronary vascular smooth muscle cells. Hiroki J; Shimokawa H; Mukai Y; Ichiki T; Takeshita A Biochem Biophys Res Commun; 2005 Jan; 326(1):154-9. PubMed ID: 15567165 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. Hiroki J; Shimokawa H; Higashi M; Morikawa K; Kandabashi T; Kawamura N; Kubota T; Ichiki T; Amano M; Kaibuchi K; Takeshita A J Mol Cell Cardiol; 2004 Aug; 37(2):537-46. PubMed ID: 15276023 [TBL] [Abstract][Full Text] [Related]
3. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438 [TBL] [Abstract][Full Text] [Related]
4. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells. Ying Z; Jin L; Palmer T; Webb RC Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763 [TBL] [Abstract][Full Text] [Related]
6. Rho-kinase is an important therapeutic target in cardiovascular medicine. Shimokawa H; Takeshita A Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741 [TBL] [Abstract][Full Text] [Related]
7. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm. Kandabashi T; Shimokawa H; Miyata K; Kunihiro I; Eto Y; Morishige K; Matsumoto Y; Obara K; Nakayama K; Takahashi S; Takeshita A Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2209-14. PubMed ID: 14592852 [TBL] [Abstract][Full Text] [Related]
8. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation. Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559 [TBL] [Abstract][Full Text] [Related]
9. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis. Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756 [TBL] [Abstract][Full Text] [Related]
11. Estrogen down-regulates nicotine-induced adhesion molecule expression via nongenomic signal pathway in endothelial cells. Wang Y; Wang Z; Wang L; Zhou Y; Zhao Y; Liu L; Yao C; Qiao Z Int Immunopharmacol; 2006 Jun; 6(6):892-902. PubMed ID: 16644474 [TBL] [Abstract][Full Text] [Related]
12. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Jaffe IZ; Mendelsohn ME Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497 [TBL] [Abstract][Full Text] [Related]
14. Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation. Harvey KA; Paranavitana CN; Zaloga GP; Siddiqui RA J Cell Physiol; 2007 May; 211(2):353-63. PubMed ID: 17167780 [TBL] [Abstract][Full Text] [Related]
15. Expression of rho A and rho kinase mRNAs in porcine vascular smooth muscle. Nishimura J; Sakihara C; Zhou Y; Kanaide H Biochem Biophys Res Commun; 1996 Oct; 227(3):750-4. PubMed ID: 8886005 [TBL] [Abstract][Full Text] [Related]
16. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444 [TBL] [Abstract][Full Text] [Related]
17. Rho kinase expression and its central role in ovine gallbladder contractions elicited by a variety of excitatory stimuli. Sahan-Firat S; Tiftik RN; Nacak M; Büyükafşar K Eur J Pharmacol; 2005 Dec; 528(1-3):169-75. PubMed ID: 16324691 [TBL] [Abstract][Full Text] [Related]
18. [Role of Rho/Rho-kinase pathway in angiotensin II signaling]. Ichiki T Nihon Rinsho; 2002 Oct; 60(10):1929-34. PubMed ID: 12397686 [TBL] [Abstract][Full Text] [Related]
19. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation. Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945 [TBL] [Abstract][Full Text] [Related]
20. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]